360 related articles for article (PubMed ID: 10906146)
1. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
4. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
5. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.
Timchenko NA; Wilde M; Iakova P; Albrecht JH; Darlington GJ
Nucleic Acids Res; 1999 Sep; 27(17):3621-30. PubMed ID: 10446255
[TBL] [Abstract][Full Text] [Related]
6. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
Carroll JS; Prall OW; Musgrove EA; Sutherland RL
J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
[TBL] [Abstract][Full Text] [Related]
7. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
Woo MS; Sánchez I; Dynlacht BD
Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
[TBL] [Abstract][Full Text] [Related]
8. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
10. The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.
Tyagi A; Agarwal C; Agarwal R
Cell Cycle; 2002; 1(2):137-42. PubMed ID: 12429923
[TBL] [Abstract][Full Text] [Related]
11. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
Lundberg AS; Weinberg RA
Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
13. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
Mateyak MK; Obaya AJ; Sedivy JM
Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
[TBL] [Abstract][Full Text] [Related]
14. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
Bandyopadhyay D; Medrano EE
Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
[TBL] [Abstract][Full Text] [Related]
15. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
18. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
[TBL] [Abstract][Full Text] [Related]
19. pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels.
Jiang H; Karnezis AN; Tao M; Guida PM; Zhu L
Oncogene; 2000 Aug; 19(34):3878-87. PubMed ID: 10951581
[TBL] [Abstract][Full Text] [Related]
20. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]